Omnicare ( OCR) pushed the Wholesale industry lower today making it today's featured Wholesale loser. The industry as a whole closed the day up 0.1%. By the end of trading, Omnicare fell 24 cents (-0.7%) to $34.96 on light volume. Throughout the day, 1.3 million shares of Omnicare exchanged hands as compared to its average daily volume of 1.8 million shares. The stock ranged in price between $34.70-$35.47 after having opened the day at $35.43 as compared to the previous trading day's close of $35.20. Other company's within the Wholesale industry that declined today were: Tessco Technologies ( TESS), down 26.7%, Wayside Technology Group ( WSTG), down 19.4%, Brightpoint ( CELL), down 11.7%, and Nash-Finch Company ( NAFC), down 3.3%. Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. Omnicare has a market cap of $4.03 billion and is part of the services sector. The company has a P/E ratio of 25.3, below the average wholesale industry P/E ratio of 46.9 and above the S&P 500 P/E ratio of 17.7. Shares are up 2.2% year to date as of the close of trading on Thursday. Currently there are five analysts that rate Omnicare a buy, no analysts rate it a sell, and three rate it a hold. TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins.
- You can view the full Omnicare Ratings Report.
- Use our wholesale section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.